Dialysis Clinical Trial
Official title:
Analysis of Emergency Department Volumes During Natural Disasters
The 'Analysis of Emergency Department Volumes during Natural Disasters' retrospective study focuses on three specified populations including dialysis patients, trauma patients, and patients poisoned by carbon monoxide. These three populations have one commonality - hurricanes, ie. natural disasters, which is the exposure. Causal associations and significant correlations will be explored in all three subgroups.
| Status | Completed |
| Enrollment | 1000 |
| Est. completion date | June 2010 |
| Est. primary completion date | May 2010 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | N/A and older |
| Eligibility |
Inclusion Criteria: - Patients with carbon monoxide poisoning in addition to trauma and dialysis patients admitted to the Memorial Hermann Health System's (MHHS) Emergency Department (ED) 1 week pre- and post-Hurricane Ike's landfall to the City of Houston, which was September 12, 2008. Exclusion Criteria: - Patients with the specified conditions that were not admitted during the time interval allotted. |
Time Perspective: Retrospective
| Country | Name | City | State |
|---|---|---|---|
| United States | Memorial Hermann Hospital - Medical Center | Houston | Texas |
| United States | University of TX Health Science Center, Houston | Houston | Texas |
| Lead Sponsor | Collaborator |
|---|---|
| The University of Texas Health Science Center, Houston |
United States,
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05031013 -
Trace Elements Concentration in Dialysis
|
||
| Not yet recruiting |
NCT03090828 -
Economic Evaluation of an Education Platform for Patients With End-stage Renal Disease
|
N/A | |
| Completed |
NCT01685372 -
Immunogenicity of Fluzone High Dose in Immunocompromised Children and Young Adults
|
Phase 2 | |
| Active, not recruiting |
NCT01394770 -
Aliskiren or Amlodipine in Hypertensive Hemodialysed Patients
|
Phase 4 | |
| Completed |
NCT00506441 -
A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With Hyperphosphatemia
|
Phase 3 | |
| Completed |
NCT00537979 -
Efficacy and Safety of 6 Months Treatment With Paricalcitol Injection or Oral in Patients With Secondary Hyperparathyroidism on Dialysis
|
Phase 4 | |
| Completed |
NCT05415969 -
CKD-aP Among Adults on Dialysis in Switzerland
|
||
| Recruiting |
NCT04024007 -
Determination of Citrate Clearance Used in Regional Anticoagulation of Continuous Venous Hemofiltration Circuits
|
||
| Completed |
NCT03772171 -
Estimate for Dietary Intakes and Hemodialysis Patients
|
||
| Recruiting |
NCT02586402 -
Safety & Efficacy of Pegolsihematide for Treatment of Anemia in Participants on Dialysis
|
Phase 2 | |
| Active, not recruiting |
NCT01693263 -
Outcome of BCF Access in Hemodialysis Patients
|
||
| Completed |
NCT01421771 -
Blood Pressure in Dialysis Patients
|
N/A | |
| Active, not recruiting |
NCT01065389 -
Resistance Training in Intradialysis Patients
|
Phase 2 | |
| Completed |
NCT00544492 -
Study of Pain, Anxiety and Complications Related to Cannulation of Arteriovenous (AV) Fistula in Chronic Hemodialysis Patients
|
Phase 4 | |
| Completed |
NCT03910426 -
Prognostic Determinants of Survival and Quality of Life in Prevalent End-stage Kidney Disease Patients
|
||
| Completed |
NCT04565522 -
Transmission of COVID-19 Virus Among Patients and Staff in Dialysis Centers
|
||
| Completed |
NCT04667741 -
Post-dialysis Recovery Time and Affecting Factors Between Turkey and Portugal
|
||
| Completed |
NCT04655989 -
A Study to Demonstrate the Safety and Effectiveness of the NIKKISO DBB-EXA ES Hemodialysis Delivery System
|
N/A | |
| Completed |
NCT05125848 -
Clinical Evaluation of the CM-1500 During Hemodialysis
|
N/A | |
| Completed |
NCT04633915 -
Antibody Response in Hemodialysis and Non-dialysis Patients Diagnosed With COVID-19.
|